CCMI
BIIB icon

Creative Capital Management Investments’s Biogen BIIB Stock Holding History

Creative Capital Management Investments’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.32K Buy
+20
New +$3.83K ﹤0.01% 461
2025
Q2 		– Sell
-92
Closed -$12.6K – 311
2025
Q1 		$12.6K Hold
92
– – ﹤0.01% 176
2024
Q4 		$14.1K Hold
92
– – 0.01% 174
2024
Q3 		$17.8K Hold
92
– – 0.01% 146
2024
Q2 		$21.3K Hold
92
– – 0.01% 127
2024
Q1 		$19.8K Buy
+92
New +$21.5K 0.01% 121

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Creative Capital Management Investments's BIIB Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in Biogen (BIIB) in Q2 2026: 20 shares worth $4.32K. The stake represents ﹤0.01% of the portfolio and ranks #461 among its holdings. This is a return to the name: Creative Capital Management Investments previously reported a position in BIIB as recently as Q1 2025.

Creative Capital Management Investments first reported a position in BIIB in Q1 2024 and has held it in 6 quarters since. The position peaked at $21.3K in Q2 2024. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Creative Capital Management Investments held 20 shares of Biogen worth $4.32K as of Q2 2026.
  • Biogen was a new Creative Capital Management Investments position in Q2 2026.
  • Biogen made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #461 holding.
  • Creative Capital Management Investments first reported a position in Biogen in Q1 2024 and has held it in 6 quarters since.
  • Creative Capital Management Investments's Biogen position peaked at $21.3K in Q2 2024.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.